Mind Medicine Inc [NASDAQ: MNMD] closed the trading session at $7.52.
The stocks have a year to date performance of 105.46 percent and weekly performance of 19.37 percent. The stock has been moved at -17.54 percent over the last six months. The stock has performed 43.24 percent around the most recent 30 days and changed 8.83 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 812.25K shares, MNMD reached to a volume of 3470268 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Mind Medicine Inc [MNMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNMD shares is $26.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNMD stock is a recommendation set at 1.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Mind Medicine Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 14, 2024. While these analysts kept the previous recommendation, ROTH MKM raised their target price to Buy. The new note on the price target was released on July 24, 2024, representing the official price target for Mind Medicine Inc stock. Previously, the target price had yet another raise to $27, while Robert W. Baird analysts kept a Outperform rating on MNMD stock.
The Average True Range (ATR) for Mind Medicine Inc is set at 0.44 The Price to Book ratio for the last quarter was 2.68, with the Price to Cash per share for the same quarter was set at 3.32.
MNMD stock trade performance evaluation
Mind Medicine Inc [MNMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.37. With this latest performance, MNMD shares gained by 43.24% in over the last four-week period, additionally sinking by -17.54% over the last 6 months – not to mention a rise of 166.67% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNMD stock in for the last two-week period is set at 70.57, with the RSI for the last a single of trading hit 76.88, and the three-weeks RSI is set at 65.15 for Mind Medicine Inc [MNMD]. The present Moving Average for the last 50 days of trading for this stock 6.04, while it was recorded at 6.52 for the last single week of trading, and 7.26 for the last 200 days.
Mind Medicine Inc [MNMD]: An insightful look at the core fundamentals
Mind Medicine Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.92 and a Current Ratio set at 5.92.
Mind Medicine Inc [MNMD]: Institutional Ownership
There are presently around $57.42%, or 58.08%% of MNMD stock, in the hands of institutional investors.
